Accelerated Pharma (Accelerated Pharma) Other Stockholders Equity : $0.00 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Other Stockholders Equity?

Accelerated Pharma's Other Stockholders Equity for the quarter that ended in Mar. 2017 was $0.00 Mil.

Accelerated Pharma's quarterly Other Stockholders Equity increased from Sep. 2016 ($0.00 Mil) to Dec. 2016 ($0.00 Mil) but then declined from Dec. 2016 ($0.00 Mil) to Mar. 2017 ($0.00 Mil).

Accelerated Pharma's annual Other Stockholders Equity increased from Dec. 2014 ($-0.00 Mil) to Dec. 2015 ($0.00 Mil) and increased from Dec. 2015 ($0.00 Mil) to Dec. 2016 ($0.00 Mil).

Accelerated Pharma Other Stockholders Equity Historical Data

The historical data trend for Accelerated Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Other Stockholders Equity Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Other Stockholders Equity

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Other Stockholders Equity	Get a 7-Day Free Trial			-	-	-	-	-

Accelerated Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Accelerated Pharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines